Pablo Tolosa

647 citations
36 papers · 229 indexed · h-index 8
Topics
Advanced Breast Cancer Therapies (26 papers)Breast Cancer Treatment Studies (10 papers)HER2/EGFR in Cancer Research (8 papers)
Partner nations
SpainUnited StatesFrance

In The Last Decade

Pablo Tolosa

32 papers receiving 229 citations

Peers

Pablo Tolosa
Comparison fields: 5 of 37
  • Oncology 154
  • Pulmonary and Respiratory Medicine 91
  • Molecular Biology 61
  • Cancer Research 50
  • Genetics 32
Replace G. Lieberman with:
G. Lieberman United States
Claudette Falato Spain
Andy Futreal United States
Wumin Dai China
Kit Fuhrman United States
David König Switzerland
Maxime Borgeaud Switzerland
Brad Foulk United States
Jaime Miguel Gomes Pita Belgium
Frank Duong United States
Pablo Tolosa relative to G. Lieberman United States G. Lieberman's profile →
Citations per field
00.5×10×15×19×
G. Lieberman · 1×
Citations per year

Countries citing papers authored by Pablo Tolosa

Since Specialization
Citations

This map shows the geographic impact of Pablo Tolosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Tolosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Tolosa more than expected).

Fields of papers citing papers by Pablo Tolosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Tolosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Tolosa. The network helps show where Pablo Tolosa may publish in the future.

Co-authorship network of co-authors of Pablo Tolosa

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Tolosa. A scholar is included among the top collaborators of Pablo Tolosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Tolosa. Pablo Tolosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 29
5 7
6 4
7 1
8 0
9 1
10 0
11 3
12 18
13 0
14 9
15 1
16 3
17 10
18 1
19 7
20 55

About Pablo Tolosa

Pablo Tolosa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 36 papers that have together received 229 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (26 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Oncology (154 citations), Cancer Research (50 citations) and Genetics (32 citations). Pablo Tolosa has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Eva Ciruelos, Tomás Pascual, Juan Miguel Cejalvo, Rodrigo Sánchez-Bayona, Carolina Martínez‐Ciarpaglini, Marisol Huerta, Guillermo Villacampa, Tania Fleitas, Noelia Tarazona and Desamparados Roda. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026